Serum levels of AFP and CA19-9 after intraoperative radiotherapy combined with drug therapy on liver and pancreatic tumors

Intraoperative radiotherapy combined with drug therapy has shown outstanding efficacy in treating liver and pancreatic tumours, effectively reducing tumour marker levels, improving liver and kidney function, reducing recurrence and metastasis rates, and improving survival rates and life quality while reducing postoperative complications and adverse reactions. This comprehensive treatment plan provides a new, effective strategy for treating liver and pancreatic tumours.